Leukemia-causing retrovirus HTLV-1 vaccine a future possibility

The fewer the deadlier
HTLV-1 establishes infection mainly in CD4+ T cells and induces leukemia. HTLV-1-encoded Tax is a critical transactivator of viral replication, but its significance in pathogenesis remained unclear. The research team showed that Tax is expressed in a fraction of leukemic cells and its expression spontaneously switches between on and off states. Credit: Kyoto University / Jun-ichirou Yasunaga

A study appearing in the in Proceedings of the National Academy of Sciences gives new clues into how cancers like leukemia form from the retrovirus HTLV-1, as well as insights into the possible creation of a vaccine.

HTLV-1 is a human retrovirus that mainly infects the CD4+ T cell. Such Infections can lead to a host of immune-related diseases including leukemia. Somewhat counterintuitively, the virus thrives by remaining at very low levels in the body, which is unlike its more notorious cousin, HIV.

"HTLV-1 RNA is rarely detected in the plasma of infected individuals, and it persists by evading host immune surveillance," says Jun-ichirou Yasunaga of Kyoto University's Institute for Frontier Life and Medical Sciences, who led the study.

HTLV-1 encodes two oncogenic factors, Tax and HBZ. Besides its function as an oncoprotein, Tax also facilitates viral replication. "The precise role of Tax in pathogenesis is unknown, since it is so faintly expressed in ," continues Yasunaga.

The researchers found that within populations of infected leukemic , only a tiny fraction—less than 3 percent—expressed Tax. Moreover, this expression in any given cell was transient, lasting less than 24 hours. However, while the cells that expressed Tax would change over time, more than 3 percent of the population would express this gene.

In fact, in vitro experiments showed that if Tax expression was suppressed in this small population, then almost all infected cells would vanish in less than a month. Furthermore, computational simulations found that it takes about five months for 90 percent of the infected cells to express Tax. This transience is advantageous for the survival of the virus, since persistent Tax expression is associated with an immune response.

Yasunaga explains that keeping the expression of Tax limited to a small population allows the infection to flourish and prevent the infected cells from undergoing controlled death, known as apoptosis. "There were clear differences in the gene expression between Tax-expressing and Tax-non-expressing cells. In the latter, there were two populations, those with medium, and those with low levels of anti-apoptotic factors. This shows that Tax caused different degrees of sensitivity to apoptosis," he explains.

Further studies revealed that this effect on apoptosis sensitivity was found in cells with better overall survivability. Yasunaga hypothesizes that even if cells stop expressing Tax, those with medium levels of anti-apoptosis factors are more resistant to apoptosis, allowing these cells to survive.

"Transient Tax expression enhances the survival and proliferation of infected cells, so it's a good vaccine target. Understanding its mechanism could be a key to new therapies," says Yasunaga.

More information: Mohamed Mahgoub et al, Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1715724115

Provided by Kyoto University
Citation: Leukemia-causing retrovirus HTLV-1 vaccine a future possibility (2018, April 13) retrieved 27 February 2024 from https://medicalxpress.com/news/2018-04-leukemia-causing-retrovirus-htlv-vaccine-future.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Mechanisms of persistent infection for the human T-cell leukemia virus


Feedback to editors